These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36004678)

  • 21. Feasibility of a Health Coaching and Home-Based Rehabilitation Intervention With Remote Monitoring for COPD.
    Benzo RP; Ridgeway J; Hoult JP; Novotny P; Thomas BE; Lam NM; V Benzo M; Kramer K; Seifert S
    Respir Care; 2021 Jun; 66(6):960-971. PubMed ID: 33906954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
    Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
    Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two faces of the same coin: a qualitative study of patients' and carers' coexistence with chronic breathlessness associated with chronic obstructive pulmonary disease (COPD).
    Ferreira DH; Kochovska S; Honson A; Phillips JL; Currow DC
    BMC Palliat Care; 2020 May; 19(1):64. PubMed ID: 32375747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients' experiences of a new integrated breathlessness support service for patients with refractory breathlessness: Results of a postal survey.
    Reilly CC; Bausewein C; Pannell C; Moxham J; Jolley CJ; Higginson IJ
    Palliat Med; 2016 Mar; 30(3):313-22. PubMed ID: 26311570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial.
    Verberkt CA; van den Beuken-van Everdingen MHJ; Dirksen CD; Schols JMGA; Wouters EFM; Janssen DJA
    Respir Med; 2021 Apr; 179():106330. PubMed ID: 33611087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX).
    Cross J; Elender F; Barton G; Clark A; Shepstone L; Blyth A; Bachmann M; Harvey I;
    Health Technol Assess; 2010 May; 14(23):1-147, iii-iv. PubMed ID: 20487638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palliative care or end-of-life care in advanced chronic obstructive pulmonary disease: a prospective community survey.
    White P; White S; Edmonds P; Gysels M; Moxham J; Seed P; Shipman C
    Br J Gen Pract; 2011 Jun; 61(587):e362-70. PubMed ID: 21801516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a Specialized Ambulatory Clinic on Refractory Breathlessness in Subjects With Advanced COPD.
    Elbehairy AF; McIsaac H; Hill E; Norman PA; Day AG; Neder JA; O'Donnell DE; Harle IA
    Respir Care; 2020 Apr; 65(4):444-454. PubMed ID: 31719189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breathlessness services as a new model of support for patients with respiratory disease.
    Bausewein C; Schunk M; Schumacher P; Dittmer J; Bolzani A; Booth S
    Chron Respir Dis; 2018 Feb; 15(1):48-59. PubMed ID: 28718321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study.
    Weingaertner V; Scheve C; Gerdes V; Schwarz-Eywill M; Prenzel R; Bausewein C; Higginson IJ; Voltz R; Herich L; Simon ST; ;
    J Pain Symptom Manage; 2014 Oct; 48(4):569-81.e1. PubMed ID: 24613784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting outcomes following holistic breathlessness services: A pooled analysis of individual patient data.
    Brighton LJ; Gao W; Farquhar M; Booth S; Bajwah S; Man WD; Reilly CC; Yi D; Higginson IJ; Maddocks M
    Palliat Med; 2019 Apr; 33(4):462-466. PubMed ID: 30764714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of guided deep breathing on breathlessness and the breathing pattern in chronic obstructive pulmonary disease: a double-blind randomized control study.
    Borge CR; Mengshoel AM; Omenaas E; Moum T; Ekman I; Lein MP; Mack U; Wahl AK
    Patient Educ Couns; 2015 Feb; 98(2):182-90. PubMed ID: 25468399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What influenced people with chronic or refractory breathlessness and advanced disease to take part and remain in a drug trial? A qualitative study.
    Lovell N; Etkind SN; Bajwah S; Maddocks M; Higginson IJ
    Trials; 2020 Feb; 21(1):215. PubMed ID: 32087745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a Motivational Interviewing-Based Health Coaching on Quality of Life in Subjects With COPD.
    Rehman H; Karpman C; Vickers Douglas K; Benzo RP
    Respir Care; 2017 Aug; 62(8):1043-1048. PubMed ID: 28611230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial.
    Farquhar MC; Prevost AT; McCrone P; Brafman-Price B; Bentley A; Higginson IJ; Todd C; Booth S
    BMC Med; 2014 Oct; 12():194. PubMed ID: 25358424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. To What Extent Do the NRS and CRQ Capture Change in Patients' Experience of Breathlessness in Advanced Disease? Findings From a Mixed-Methods Double-Blind Randomized Feasibility Trial.
    Lovell N; Etkind SN; Bajwah S; Maddocks M; Higginson IJ
    J Pain Symptom Manage; 2019 Sep; 58(3):369-381.e7. PubMed ID: 31201877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-Effectiveness of a Specialized Breathlessness Service Versus Usual Care for Patients With Advanced Diseases.
    Seidl H; Schunk M; Le L; Syunyaeva Z; Streitwieser S; Berger U; Mansmann U; Szentes BL; Bausewein C; Schwarzkopf L
    Value Health; 2023 Jan; 26(1):81-90. PubMed ID: 36182632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Openness Personality Trait Associated With Benefit From a Nonpharmacological Breathlessness Intervention in People With Intrathoracic Cancer: An Exploratory Analysis.
    Johnson MJ; Nabb S; Booth S; Kanaan M
    J Pain Symptom Manage; 2020 May; 59(5):1059-1066.e2. PubMed ID: 32006612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and management of chronic breathlessness in COPD in a tertiary care center.
    Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F;
    BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: a pragmatic fast-track randomised controlled trial (BreathEase).
    Schunk M; Le L; Syunyaeva Z; Haberland B; Tänzler S; Mansmann U; Schwarzkopf L; Seidl H; Streitwieser S; Hofmann M; Müller T; Weiß T; Morawietz P; Rehfuess EA; Huber RM; Berger U; Bausewein C
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33509957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.